Corline Biomedical AB

Corline Biomedical ABverified

CLBIO.ST

Price:

$16.4

Market Cap:

$401.65M

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; CHC, which is used for the treatment of soft tissue injuries; medical devices; and CHS, a coronary stent. The company was founded in 1991 and is based in Uppsala, Sweden.

Industry

Biotechnology

IPO Date

2015-06-03

Stock Exchange

STO

Ticker

CLBIO.ST

The PE Ratio as of December 2025 (TTM) for Corline Biomedical AB (CLBIO.ST) is -15.77

According to Corline Biomedical AB’s latest financial reports and current stock price. The company's current PE Ratio is -15.77. This represents a change of -20.09% compared to the average of -19.74 of the last 4 quarters.

Corline Biomedical AB (CLBIO.ST) Historical PE Ratio (quarterly & annually)

How has CLBIO.ST PE Ratio performed in the past?

The mean historical PE Ratio of Corline Biomedical AB over the last ten years is -30.67. The current -15.77 PE Ratio has changed 5.04% with respect to the historical average. Over the past ten years (40 quarters), CLBIO.ST's PE Ratio was at its highest in in the September 2023 quarter at 441.22. The PE Ratio was at its lowest in in the December 2020 quarter at -1101.87.

Quarterly (TTM)
Annual

Average

-30.67

Median

-24.81

Minimum

-177.01

Maximum

85.08

Corline Biomedical AB (CLBIO.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Corline Biomedical AB PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 101.76%

Maximum Annual PE Ratio = 85.08

Minimum Annual Increase = -308.06%

Minimum Annual PE Ratio = -177.01

Quarterly (TTM)
Annual
YearPE RatioChange
2024-8.26-95.34%
2023-177.01-308.06%
202285.08-297.17%
2021-43.1526.13%
2020-34.2130.00%
2019-26.32-36.98%
2018-41.76101.76%
2017-20.70-11.15%
2016-23.2936.02%
2015-17.13-36.53%

Corline Biomedical AB (CLBIO.ST) Average PE Ratio

How has CLBIO.ST PE Ratio performed in the past?

The current PE Ratio of Corline Biomedical AB (CLBIO.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-33.40

5-year avg

-35.51

10-year avg

-30.67

Corline Biomedical AB (CLBIO.ST) PE Ratio vs. Peers

How is CLBIO.ST’s PE Ratio compared to its peers?

Corline Biomedical AB’s PE Ratio is less than Magle Chemoswed Holding AB (publ) (-11.80), less than Mendus AB (publ) (-2.50), less than Enzymatica AB (publ) (-7.80), greater than Elicera Therapeutics AB (publ) (-20.58), less than Ascelia Pharma AB (publ) (-3.97), less than FluoGuide A/S (-9.26), less than Xintela AB (publ) (-4.09), less than Intervacc AB (publ) (-4.74), greater than Bactiguard Holding AB (publ) (-29.48), less than Bio-Works Technologies AB (publ) (-6.13),

Build a custom stock screener for Corline Biomedical AB (CLBIO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corline Biomedical AB using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corline Biomedical AB (CLBIO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corline Biomedical AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Corline Biomedical AB's PE Ratio?

How is the PE Ratio calculated for Corline Biomedical AB (CLBIO.ST)?

What is the highest PE Ratio for Corline Biomedical AB (CLBIO.ST)?

What is the 3-year average PE Ratio for Corline Biomedical AB (CLBIO.ST)?

What is the 5-year average PE Ratio for Corline Biomedical AB (CLBIO.ST)?

How does the current PE Ratio for Corline Biomedical AB (CLBIO.ST) compare to its historical average?